These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9469239)

  • 1. Neurocognitive correlates of positive and negative syndromes in schizophrenia.
    Voruganti LN; Heslegrave RJ; Awad AG
    Can J Psychiatry; 1997 Dec; 42(10):1066-71. PubMed ID: 9469239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive deficits and neurological signs in schizophrenia.
    Wong AH; Voruganti LN; Heslegrave RJ; Awad AG
    Schizophr Res; 1997 Feb; 23(2):139-46. PubMed ID: 9061810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia.
    Berman I; Viegner B; Merson A; Allan E; Pappas D; Green AI
    Schizophr Res; 1997 May; 25(1):1-10. PubMed ID: 9176922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive profile and its association with psychopathology in first-degree relatives of patients with schizophrenia. a case-control study.
    Scala S; Lasalvia A; Cristofalo D; Bonetto C; Ruggeri M
    Psychiatry Res; 2012 Dec; 200(2-3):137-43. PubMed ID: 22652345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Executive-frontal lobe cognitive dysfunction in schizophrenia: a symptom subtype analysis.
    Mahurin RK; Velligan DI; Miller AL
    Psychiatry Res; 1998 Jun; 79(2):139-49. PubMed ID: 9705052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neuropsychological study of prefrontal lobe function in the positive and negative subtypes of schizophrenia.
    Mattson DT; Berk M; Lucas MD
    J Genet Psychol; 1997 Dec; 158(4):487-94. PubMed ID: 9423278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight, neurocognitive function and symptom clusters in chronic schizophrenia.
    Collins AA; Remington GJ; Coulter K; Birkett K
    Schizophr Res; 1997 Oct; 27(1):37-44. PubMed ID: 9373893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia.
    Woon PS; Chia MY; Chan WY; Sim K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):463-8. PubMed ID: 20109511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of neurocognition between drug-free patients with schizophrenia and bipolar disorder.
    Tam WC; Liu Z
    J Nerv Ment Dis; 2004 Jul; 192(7):464-70. PubMed ID: 15232316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive functioning as an intermediary variable between psychopathology and insight in schizophrenia.
    Hwang SS; Ahn YM; Kim YS
    Psychiatry Res; 2015 Dec; 230(3):792-9. PubMed ID: 26602231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia.
    Heslegrave RJ; Awad AG; Voruganti LN
    J Psychiatry Neurosci; 1997 Jul; 22(4):235-43. PubMed ID: 9262045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive deficit measures in schizophrenia: factor structure and clinical correlates.
    Lieh-Mak F; Lee PW
    Am J Psychiatry; 1997 Jun; 154(6 Suppl):39-46. PubMed ID: 9167543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Card-sort performance and syndromes of schizophrenia.
    Rowe EW; Shean G
    Genet Soc Gen Psychol Monogr; 1997 May; 123(2):197-209. PubMed ID: 9204545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and clinical correlates of prospective memory performance in first-episode schizophrenia.
    Zhou FC; Xiang YT; Wang CY; Dickerson F; Au RW; Zhou JJ; Zhou Y; Shum DH; Chiu HF; Man D; Lee EH; Yu X; Chan RC; Ungvari GS
    Schizophr Res; 2012 Mar; 135(1-3):34-9. PubMed ID: 22222379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopathology and Wisconsin Card Sorting Test performance in male schizophrenic patients: influence of dual diagnosis.
    Rodriguez-Jimenez R; Aragües M; Jimenez-Arriero MA; Ponce G; Martinez I; Hoenicka J; Rubio G; Palomo T;
    Psychopathology; 2008; 41(1):58-64. PubMed ID: 17975329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter?
    Varga M; Magnusson A; Flekkøy K; David AS; Opjordsmoen S
    Compr Psychiatry; 2007; 48(6):583-91. PubMed ID: 17954145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of affect recognition with psychopathology and cognitive performance in schizophrenia.
    Bozikas VP; Kosmidis MH; Anezoulaki D; Giannakou M; Karavatos A
    J Int Neuropsychol Soc; 2004 Jul; 10(4):549-58. PubMed ID: 15327733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between negative symptoms and neurocognitive functions in adolescent and adult patients with first-episode schizophrenia.
    Huang M; Huang Y; Yu L; Hu J; Chen J; Jin P; Xu W; Wei N; Hu S; Qi H; Xu Y
    BMC Psychiatry; 2016 Oct; 16(1):344. PubMed ID: 27716115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.